Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Status:
Terminated
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
This clinical trial compares the relative efficacy of treating acute exacerbations of
relapsing forms of Multiple Sclerosis with equivalent doses of oral and intravenous (IV)
methylprednisolone. This is a randomized, blinded, multi-center study.